Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains

被引:0
作者
Farnsworth, Christopher W. [2 ]
Roemmich, Brittany [2 ]
Spears, Grant M. [3 ]
Murray, David L. [3 ]
Dispenzieri, Angela [3 ]
Willrich, Maria Alice V. [1 ]
机构
[1] Mayo Clin Rochester, Dept Lab Med & Pathol, 200 First St SW, Rochester, MN 55905 USA
[2] Washington Univ St Louis, St Louis, MO USA
[3] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
关键词
free light chains; immunoassays; reference intervals; method comparison; nephelometry; ELISA; MONOCLONAL GAMMOPATHY; SERUM; MYELOMA; DIAGNOSIS; CRITERIA; RATIO;
D O I
10.1515/cclm-2023-0912
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives Free light chain (FLC) assays and the ratio of kappa/lambda are recommended for diagnosis, prognosis and monitoring of plasma cell dyscrasias (PCD). Limited data exists on FLC clinical specificity in patients diagnosed with other conditions.Methods We assessed the kappa, lambda, and kappa/lambda FLC ratio using the FreeLite assay and the Sebia FLC ELISA assay in 176 patients with clinical presentations of fatigue, anemia, polyclonal hypergammaglobulinemia, joint disorders, kidney disease and non PCD-cancers with no monoclonal protein observed on serum protein electrophoresis or MASS-FIX immunoglobulin isotyping. Manufacturer defined reference intervals (RI) and glomerular filtration rate (GFR) specific RI (renal RI) were utilized.Results For the kappa/lambda ratio, 68.7 % (121/176) of specimens on the FreeLite and 87.5 % (154/176) of specimens on the Sebia assay were within RI. For kappa, 68.2 % (120/176) and 72.2 % (127/176) of results were outside RI for FreeLite and Sebia respectively. For lambda, 37.5 % (66/176) and 84.1 % (148/176) of FreeLite and Sebia results were outside RI. With FreeLite and Sebia, patients with kidney disease (n=25) had the highest kappa/lambda ratios. 44 patients (25.0 %) had GFR <60 mL/min/BSA. When renal RI were applied, 13.6 % had a FLCr outside the renal RI with FreeLite, and 4.5 % with Sebia.Conclusions In a cohort of patients with signs and symptoms suggestive of PCDs, but ultimately diagnosed with other conditions, Sebia FLC had improved clinical specificity relative to FreeLite, if one was using an abnormal kappa/lambda ratio as a surrogate for monoclonality.
引用
收藏
页码:929 / 938
页数:10
相关论文
共 30 条
  • [1] Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent
    Caponi, Laura
    Koni, Elona
    Romiti, Nadia
    Paolicchi, Aldo
    Franzini, Maria
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (02) : 221 - 229
  • [2] Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study
    Cotten, Steven W.
    Shajani-Yi, Zahra
    Cervinski, Mark A.
    Voorhees, Timothy
    Tuchman, Sascha A.
    Korpi-Steiner, Nichole
    [J]. CLINICAL BIOCHEMISTRY, 2018, 58 : 100 - 107
  • [3] Method comparison of four clinically available assays for serum free light chain analysis
    Fleming, Cherina K. A.
    Swarttouw, Tim
    Angelino, Corrie M. de Kat
    Jacobs, Joannes F. M.
    Russcher, Henk
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (01) : 85 - 94
  • [4] The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosis
    Gatt, Moshe E.
    Kaplan, Batia
    Yogev, Dean
    Slyusarevsky, Elana
    Pogrebijski, Galina
    Golderman, Sizilia
    Kukuy, Olga
    Livneh, Avi
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) : 86 - 92
  • [5] Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease
    Hutchison, Colin A.
    Harding, Stephen
    Hewins, Pete
    Mead, Graham P.
    Townsend, John
    Radwell, Arthur R. B.
    Cockwell, Paul
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06): : 1684 - 1690
  • [6] Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
    Hutchison, Colin A.
    Plant, Tim
    Drayson, Mark
    Cockwell, Paul
    Kountouri, Melpomeni
    Basnayake, Kolitha
    Harding, Stephen
    Bradwell, Arthur R.
    Mead, Graham
    [J]. BMC NEPHROLOGY, 2008, 9 (1)
  • [7] New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race
    Inker, Lesley A.
    Eneanya, Nwamaka D.
    Coresh, Josef
    Tighiouart, Hocine
    Wang, Dan
    Sang, Yingying
    Crews, Deidra C.
    Doria, Alessandro
    Estrella, Michelle M.
    Froissart, Marc
    Grams, Morgan E.
    Greene, Tom
    Grubb, Anders
    Gudnason, Vilmundur
    Gutierrez, Orlando M.
    Kalil, Roberto
    Karger, Amy B.
    Mauer, Michael
    Navis, Gerjan
    Nelson, Robert G.
    Poggio, Emilio D.
    Rodby, Roger
    Rossing, Peter
    Rule, Andrew D.
    Selvin, Elizabeth
    Seegmiller, Jesse C.
    Shlipak, Michael G.
    Torres, Vicente E.
    Yang, Wei
    Ballew, Shoshana H.
    Couture, Sara J.
    Powe, Neil R.
    Levey, Andrew S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (19) : 1737 - 1749
  • [8] N Latex FLC serum free light-chain assays in patients with renal impairment
    Jacobs, Joannes F. M.
    Hoedemakers, Rein M. J.
    Teunissen, Elisa
    te Velthuis, Henk
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (06) : 853 - 859
  • [9] FLC polymerization: Another hurdle towards standardization of FLC measurements
    Kaplan, Batia
    Jacobs, Joannes F. M.
    [J]. CLINICA CHIMICA ACTA, 2021, 515 : 42 - 43
  • [10] Katzmann JA, 2002, CLIN CHEM, V48, P1437